The PRIME trial tested whether the dynamic contrast enhancement sequence in multiparametric MRI is truly necessary to improve significant prostate cancer ...

Several medical conditions can mimic prostate cancer, causing many of the same symptoms, including painful ejaculation and ...

A British father-of-two was diagnosed with prostate cancer after his “gut feeling” led him to push for treatment, despite ...

Alpenglow Biosciences, a leader in AI-powered 3D pathology, today announced a strategic agreement with Virdx, a biophysics AI ...

Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...

Dr. Wallen: PSA can vary even day by day in patients for a lot of reasons. First of all, PSA is not a cancer specific test.

Art Imaging By Trish Yerges for Grande Ronde Hospital September is Prostate Cancer Awareness Month—a reminder that men age 50 ...

Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI.

New technologies and treatment methods are expanding men’s options. Here’s what you should know about your choices for prostate cancer care.

Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has ...

The travel writer and host of 'Rick Steves Europe' shares an update after prostate cancer diagnosis to encourage men to 'say ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...